985-P: oral semaglutide as add-on to insulin in T2D: PIONEER 8
A GLP-1 drug like Ozempic may be a better first-line treatment choice for those patients
Given that approximately 70% of OSA patients are overweight or obese, and weight reduction of 10-15% can significantly improve breathing during sleep, medications that promote meaningful weight loss may offer adjunctive benefits alongside standard treatments like CPAP therapy
Pharma Industry 6 min read In weight loss battle, Novo and Lilly face growing offensive from licenced copies Ozempic's patented semaglutide ingredient is also used in Novo's wildly popular obesity treatment Wegovy and diabetes tablets Rybelsus, while Lilly's tirzepatide is used in Mounjaro and Zepbound
[7] (This interaction is not significant when levodopa is combined with carbidopa, as in standard carbidopa/levodopa therapy, because carbidopa prevents peripheral levodopa breakdown.) Another notable interaction involves the chemotherapeutic agent altretamine: coadministration of pyridoxine can decrease altretamines effectiveness and is generally advised against unless specifically directed
doi:10.1136/bmjopen-2018-023830 173
